Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies
Clinical Lab Manager | May 24, 2022
Join Clinical Lab Manager and David Miklos, MD, PhD, to discuss recent advances in bispecific CAR-T therapy and biomarkers for characterizing CAR-T product quality.